Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Breast Cancer: Current Research received 114 citations as per Google Scholar report
Journal Impact Factor 0.29*
Submit manuscript at or send as an e-mail attachment to the Editorial Office at manuscript@omicsonline.org
If you are interested in publishing with us or have any questions, please feel free to contact us directly on WhatsApp .
Smoking causes a number of diseases and is linked to a higher risk of breast cancer in younger, premenopausal women. Smoking also can increase complications from breast cancer treatment such as damage to the lungs from radiation therapy and difficulty healing after surgery and breast reconstruction.
Related Journals of Smoking in Breast Cancer
Advances in Cancer Prevention, Cancer Clinical Trials, Cancer Medicine & Anti Cancer Drugs, Oncology & Cancer Case Reports, Cancer detection and prevention, Cancer biotherapy, Breast cancer research and treatment, Research In Cancer and Tumor, Breast Diseases
OMICS International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS International hosts over 700 leading-edge peer reviewed Open Access Journals and organize over 1000 International Conferences annually all over the world. OMICS International journals have over 10 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 50000 eminent personalities that ensure a rapid, quality and quick review process. OMICS International signed an agreement with more than 1000 International Societies to make healthcare information Open Access. OMICS International Conferences make the perfect platform for global networking as it brings together renowned speakers and scientists across the globe to a most exciting and memorable scientific event filled with much enlightening interactive sessions, world class exhibitions and poster presentations.
Mastectomy is surgery to remove all breast tissue from a breast as a way to treat or prevent breast cancer. For those with early-stage breast cancer, mastectomy may be one treatment option. Breast-conserving surgery (lumpectomy), in which only the tumor is removed from the breast, may be another option.
Related Journals of Mastectomy
Gynecology & Obstetrics, Cancer Science & Therapy, Cancer Diagnosis, Archives in Cancer Research, Clinical Breast Cancer, Breast diseases, Cancer detection and prevention, Research In Cancer and Tumor
Hereditary Breast and Ovarian Cancer (HBOC) should be considered when there are multiple cases of breast cancer on the same side of the family. There is breast cancer in multiple generations on the same side of the family, such as having both a grandmother and an aunt on your father’s side diagnosed. A woman is diagnosed with a second breast cancer in the same or the other breast or has both breast and ovarian cancers.
Related Journals of Hereditary Breast Cancer
Oncology & Cancer Case Reports, Gynecology & Obstetrics, Cancer Science & Therapy, Cancer Diagnosis, Hereditary Cancer in Clinical Practice, Cancer Biology & Therapy, Cancer Treatment Reviews, Breast cancer, Breast journal, current breast cancer reports, The Japanese Breast Cancer Society
Breast cancer is a huge opponent in the world of women, but terminal cancer is something that just boggles the mind and heart of any man or woman.
Related Journals of Terminal Breast Cancer
Advances in Cancer Prevention, Cancer Clinical Trials, Cancer Medicine & Anti Cancer Drugs, Oncology & Cancer Case Reports, Journal of Cancer Research and Experimental Oncology, Journal of Cancer Epidemiology, Infectious Agents and Cancer, Middle East Journal of Cancer, Current breast cancer reports
Each three-to five-mile Making Strides Against Breast Cancer walk is a capable and raising chance to unite as a group to respect breast growth survivors, bring issues to light about steps we can take to diminish the danger of getting bosom tumor, and raise cash to help the American Cancer Society lead the battle against this malady with earth shattering bosom malignancy research, data and bolster all day, every day, and access to mammograms for ladies who need them.
Related Journals of Making Strides in Breast Cancer
Cancer Diagnosis, Archives in Cancer Research, Cancer Surgery, Clinical & Experimental Oncology, Lung Cancer Diagnosis & Treatment, The Breast, Breast Diseases, Gastric and Breast Cancer, Breast Diseases: A Year Book Quarterly, Open Access Cancer Journals
Studies keep on uncovering way of life components and propensities that change bosom malignancy hazard. Progressing studies are taking a gander at the impact of activity, weight pick up or misfortune, and eating routine on bosom tumor hazard. New Advances in Breast cancer treatment are: Chemoprevention, Settling on choices about DCIS, New lab tests, Circling tumor cells, More up to date imaging tests,Oncoplastic surgery, New chemotherapy drugs, Bisphosphonates, Denosumab, Mastectomy.
Related Journals of Advances in Breast Cancer Treatment
Advances in Cancer Prevention, Cancer Clinical Trials, Cancer Medicine & Anti Cancer Drugs, Oncology & Cancer Case Reports, Cancer Treatment Communications, Cancer Treatment Reviews, Breast cancer research and treatment, Cancer research and treatment, Cancer treatment reviews, Current treatment options in oncology, Journal of cancer research and treatment, Advances in cancer research
Inflammatory breast cancer (IBC) is an uncommon and extremely forceful infection in which cancer cells block lymph vessels in the skin of the breast. This sort of breast disease is called "provocative" on the grounds that the bosom frequently looks swollen and red, or "excited." Inflammatory breast cancer usually starts with the reddening and swelling of the breast instead of a distinct lump. IBC tends to grow and spread quickly with the symptoms of breast warmth, breast may become harder, thickening of the skin of the breast, redness involving more than one third of the breast.
Related Journals of Inflammatory Breast Cancer
Cancer Medicine & Anti Cancer Drugs, Oncology & Cancer Case Reports, Gynecology & Obstetrics, Cancer Science & Therapy Cancer Informatics, Cancer Imaging, Cancers, Cancer Management and Research, Cancer and Clinical Oncology, BMC Cancer, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Inflammation, Inflammo Pharmacology
Intrusive ductal carcinoma (IDC), once in a while called invading ductal carcinoma, is the most well-known kind of breast tumor. Around 80% of all breast growths are intrusive ductal carcinomas. Intrusive implies that the growth has "attacked" or spread to the encompassing breast tissues.
Related Journals of Invasive Ductal Carcinoma
Oncology & Cancer Case Reports, Gynecology & Obstetrics, Cancer Science & Therapy, Cancer Diagnosis, Breast journal, Breast cancer online, Cancer therapy, Cancer gene therapy, Integrative cancer therapies
Breast cancer therapeutic & market analysis assesses marketed and investigational products and combination regimens for the global breast cancer therapeutics market. Segmentation by drug class is provided, along with supporting information, such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology. Marketed and pipeline products are broadly segmented into hormonal therapy, targeted therapy, chemotherapy, and other therapies of current global interest.
Related Journals of Breast Cancer Therapeutic & Market Analysis
Gynecology & Obstetrics, Cancer Science & Therapy, Cancer Diagnosis, Archives in Cancer Research, Cancer gene therapy, Cancer chemotherapy and pharmacology, Integrative cancer therapies, Cancer therapy, Journal of cancer research and therapeutics, Molecular cancer therapeutics, Journal for immunotherapy of cancer, International journal of cancer therapy and oncology, Cancer immunology immunotherapy
Breast cancer research into the causes, prevention, and treatment of breast cancer is being done in many medical centers throughout the world. Studies continue to find lifestyle factors and habits that alter breast cancer risk. Some studies are looking at the effect of exercise, weight gain or loss, and diet on breast cancer risk. We are also learning more about how genes influence breast cancer. This should happen more quickly now that the human genome has been mapped out.
Related Journals of Breast Cancer Research
Advances in Cancer Prevention, Cancer Clinical Trials, Cancer Medicine & Anti Cancer Drugs, Oncology & Cancer Case Reports, Expert review of anticancer therapy, Cancer research, American journal of cancer research, Leukemia research, Journal of cancer research and clinical oncology, Journal of cancer research and therapeutics, Chinese journal of cancer research, Progress in tumor research
Radiotherapy is a treatment for cancer that uses carefully measured and controlled high energy x-rays. Radiation to the breast is often given after breast-conserving surgery to help lower the chance that the cancer will come back in the breast or nearby lymph nodes. External beam radiation is the most common type of radiation therapy for women with breast cancer.
Related journals of Breast Cancer Radiotherapy
Cancer Clinical Trials, Cancer Medicine & Anti Cancer Drugs, Oncology & Cancer Case Reports, Gynecology & Obstetrics, Cancer biotherapy and radiopharmaceuticals, Anti-cancer drugs, International breast feeding journal, Breast Cancer Online
Breast Cancer: Current Research is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research of breast cancer. Breast Cancer: Current Research aims to publish articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is to develop a new focus and new perspectives for all who are concerned with breast cancer. Breast Cancer: Current Research presents the open access articles in all areas of biology and medicine relevant to breast cancer, including invasive ductual carcinoma, with special emphasis on the inflammatory breast cancer, Breast cancer cure, and advances in Breast cancer treatment. In addition to basic research, the journal publishes mastectomy, alternative treatments for breast cancer, Fibrocystic breast, mammography, etc.
This scholarly publishing Editorial Manager System for quality in the review process. Editorial Manager System is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of Breast Cancer: Current Research or outside experts; at least two independent reviewer’s approval followed by the editor is required for the acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.
Immunotherapy harnesses the body's immune system to fight cancer by targeting specific cancer cells while sparing healthy tissues. This approach involves using immune checkpoint inhibitors, monoclonal antibodies, and cancer vaccines to enhance the immune response against tumors. Recent advancements have shown promising results in treating various cancers, including breast cancer. By overcoming the tumor's ability to evade immune detection, immunotherapy offers a novel and increasingly effective treatment option.
Cancer stem cells (CSCs) are a subpopulation of cancer cells with the ability to self-renew and drive tumor growth. These cells are thought to contribute to tumor recurrence and resistance to conventional treatments due to their unique properties. Targeting CSCs presents a promising strategy to improve treatment outcomes by addressing the root cause of cancer persistence. Research is focused on identifying specific markers and pathways associated with CSCs to develop more effective therapies.
Molecular profiling involves analyzing a tumor's genetic, genomic, and molecular characteristics to tailor personalized treatment strategies. By identifying specific mutations, gene expressions, and molecular signatures, this approach helps predict which therapies are most likely to be effective for individual patients. Molecular profiling can enhance precision medicine by targeting treatments based on a patient's unique cancer profile rather than a one-size-fits-all approach.
Tumor biomarkers are molecules or substances found in blood, tissues, or other bodily fluids that indicate the presence or progression of cancer. They can be proteins, genes, or other indicators linked to tumor activity and help in diagnosing, predicting prognosis, and monitoring treatment responses. Biomarkers are essential for personalizing treatment plans and assessing the effectiveness of therapies. Advancements in biomarker research aim to improve early detection and precision medicine.
Fast Editorial Execution and Review Process (FEE-Review Process):
Breast Cancer: Current Research is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.
The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.
Articles published in Breast Cancer: Current Research have been cited by esteemed scholars and scientists all around the world. Breast Cancer: Current Research has got h-index 6, which means every article in Breast Cancer: Current Research has got 6 average citations.
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals